Speaking Engagements Broaden Discussion on Unsustainable Drug Prices

John Rother to Make Appearances at AMA National Advocacy Conference and National Conference of Insurance Legislators. 

Washington, D.C. – In two separate appearances this week, National Coalition on Health Care President and CEO John Rother will speak with health care leaders about the unsustainable threat of higher drug prices.  Rother will provide his perspective as part of the ongoing Campaign for Sustainable Rx Pricing which is supported by providers, consumer advocates, payers, and other health care stakeholders.

The Campaign for Sustainable Rx Pricing which launched last year has sought to bring stakeholders together to develop important solutions to the challenge of ever escalating drug prices.  The Campaign launched in the shadow of Gilead’s Hepatitis C treatment Sovaldi which was priced at $84,000 per treatment — or $1,000 per pill.  Since the launch Rother has expanded the scope of the campaign to focus on the looming impact of newer, more expensive drugs to treat other, more prevalent diseases and health conditions.

Rother’s first appearance will be at the American Medical Association’s National Advocacy Conference in Washington, D.C. Here he will speak to doctors from all over the nation about the unsustainable trend of high cost drugs and the impact it is having on access to life-saving treatments for patients.  Click here to learn more about the conference.

On Saturday, Rother will take part in a panel discussion at the National Conference of Insurance Legislators Spring Meeting.  The panel which is titled, “Drug Prices: How Much Is Too Much? And Where Will States Draw the Line?” will help bring attention to the impact of higher drug prices on state budgets and what can be done.  Click here to learn more about the NCOIL Spring Meeting.

###

The Campaign for Sustainable Rx Pricing (CSRxP) is a project of the National Coalition on Health Care, the oldest and most diverse group working to achieve comprehensive health system reform representing more than 80 participating organizations, including medical societies, businesses, unions, health care providers, faith-based associations, pension and health funds, insurers and groups representing consumers, patients, women, minorities and persons with disabilities. Member organizations collectively represent – as employees, members, or congregants – over 100 million Americans. CSRxP aims to spark a national dialogue about the need to find market-driven solutions to the problems caused by the onslaught of new high-priced prescription medicines. Follow CSRxP on Twitter.